Manufacturing Science & Technology (MS&T) Co-op
Beam Therapeutics
Summary
Beam is looking for a highly motivated and detail-oriented Manufacturing Sciences & Technology Co-op to join our Technical Operations organization from January through June 2027. This role offers an opportunity to gain hands-on experience supporting late-stage clinical cell therapy manufacturing operations through projects focused on aseptic process simulation (APS), process validation, and regulatory inspection readiness. Under the guidance of their mentor, the co-op will support strategic initiatives that strengthen process understanding, sterility assurance, and manufacturing process robustness while collaborating across Manufacturing, Quality, Validation, and Technical Operations functions.
Job description
Responsibilities
- Develop a project plan, define objectives and desired outcomes, engage cross-functional stakeholders, and execute against established timelines.
- Support the lifecycle management of the site's Aseptic Process Simulation (APS) program, including protocol development, execution support, data analysis, and report generation.
- Support activities related to Pre-License Inspection (PLI) readiness, including document review, data verification, and inspection support preparation.
- Prepare technical summaries and presentations for MSAT leadership and cross-functional stakeholders.
- Maintain compliant documentation practices in accordance with GMP requirements.
Qualifications
- Currently pursuing a Bachelor's or Master's degree in Chemical Engineering, Bioengineering, Biomedical Engineering, Biotechnology, or a related scientific discipline.
- Must be entering their third or fourth year of undergraduate study or currently pursuing a Master's degree.
- Strong interest in biopharmaceutical manufacturing, cell therapy, sterile manufacturing, or GMP operations.
- Excellent written, verbal, and interpersonal communication skills.
- Strong organizational skills and attention to detail.
- Ability to work effectively within a fast-paced, cross-functional environment.
- Proficiency with Microsoft Office applications including Excel, Word, and PowerPoint.
- Ability to work onsite in Durham, NC
- Ability to occasionally enter manufacturing and laboratory environments while following applicable gowning and safety requirements.
- Ability to sit, stand, and use a computer for extended periods.
- This role follows a hybrid work schedule and requires onsite attendance 4-5 days per week.
- Applicants must be currently enrolled in a degree-granting college or university program and maintain their student status throughout the duration of the internship/co-op to be eligible.
Requirements
- Currently pursuing a Bachelor's or Master's degree in Chemical Engineering, Bioengineering, Biomedical Engineering, Biotechnology, or a related scientific discipline.
- Must be entering their third or fourth year of undergraduate study or currently pursuing a Master's degree.
- Strong interest in biopharmaceutical manufacturing, cell therapy, sterile manufacturing, or GMP operations.
- Excellent written, verbal, and interpersonal communication skills.
- Strong organizational skills and attention to detail.
- Ability to work effectively within a fast-paced, cross-functional environment.
- Proficiency with Microsoft Office applications including Excel, Word, and PowerPoint.
- Ability to work onsite in Durham, NC
- Ability to occasionally enter manufacturing and laboratory environments while following applicable gowning and safety requirements.
- Ability to sit, stand, and use a computer for extended periods.
- This role follows a hybrid work schedule and requires onsite attendance 4-5 days per week.
- Applicants must be currently enrolled in a degree-granting college or university program and maintain their student status throughout the duration of the internship/co-op to be eligible.
Company overview
Beam Therapeutics is a pioneering biotechnology company focused on developing precision genetic medicines through base editing technology. Founded by leading CRISPR researchers, the company leverages its proprietary base editing platform to create therapies that can make precise, single-letter changes to DNA without causing double-strand breaks. Beam's innovative approach addresses genetic diseases at their source by correcting point mutations that cause various inherited disorders. The company's pipeline includes programs targeting sickle cell disease, beta-thalassemia, and other genetic conditions. Beam Therapeutics represents the next generation of gene editing companies, building upon CRISPR technology to enable more precise and potentially safer genetic modifications. The company has established strategic partnerships and collaborations to advance its therapeutic programs and expand the applications of its base editing technology across multiple disease areas.